Solis Mammography, an independent provider of breast imaging services, believes that an educated patient makes the best decisions about their health. For this reason, Solis is urging support for Texas House Bill 1036, which if passed, would require all commercial insurance providers in Texas to cover digital breast tomosynthesis, also known as 3-D mammography, for breast cancer screening and diagnosis. House Bill 1036 was introduced on Jan. 1 by Texas Rep. Senfronia Thompson (D-Houston).

March 9, 2017 — Piramal Imaging SA and Isologic Innovative Radiopharmaceuticals recently announced that Health Canada has issued a Notice of Compliance (NOC) to the latter for NeuraCeq (florbetaben F-18 injection). Isologic has received marketing authorization from Health Canada for the commercial production and market supply of NeuraCeq in Canada.

Michigan Medicine and the University of Michigan have launched the nation’s first prostate cancer risk clinic, designed to provide individualized and structured care for men with a genetic predisposition to prostate cancer.

Brain imaging scans may one day provide useful information on the response to psychotherapy in patients with depression or anxiety, according to a review of current research in the November/December issue of the Harvard Review of Psychiatry.

Through computed tomography (CT) images of the heart and other types of imaging, build-up of dangerous coronary plaques — which restrict the flow of blood to the heart — can be detected, even before a person develops symptoms of heart disease. Because of this, there is increasing interest in using these imaging techniques to screen for heart disease. According to a review published recently in JACC:  Cardiovascular Imaging, a simple CT imaging technique called a coronary artery calcium (CAC) scan—often referred to as a calcium scan—may be particularly useful when screening for coronary artery disease.

Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set for an invigorating year, according to a new analysis from Frost & Sullivan. This outlook is due to a partial realization of major healthcare policies and initiatives, technology advancements and value-based care driving the adoption and need for consumer-centric targeted therapies. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g. China, India, Brazil) which demonstrate high growth opportunities compared developed markets (e.g., the United States and Western Europe. Growing at a CAGR of 4.8 percent, the industry is likely to reach revenue of $1,731.8 billion.

Healthcare imaging specialist Barco has expanded its diagnostic display toolset for a more intuitive workflow with new features to support radiologists with their increasingly busy and demanding workload. The new additions were developed to increase visibility of subtle details and better control the reading environment.

Navidea Biopharmaceuticals announced the completion of the sale of its Lymphoseek product to Cardinal Health. Navidea received approximately $83 million at closing, and will have the opportunity to earn up to $227 million of contingent consideration based on certain milestones through 2026, with $17.1 million of that amount guaranteed over the next three years.

The SIGNA Architect delivers a digitized 128-channel RF chain to increase SNR in MSK imaging. The large, homogeneous FOV in a 70 cm wide bore allows visualization of any type of MSK anatomy, even the smallest lesions in the most challenging areas of the body.

March 7, 2017 — Unfors RaySafe recently introduced the RaySafe i3, to its suite of real-time dosimetry products, at the European Society of Radiology in Vienna.

The RaySafe Real-Time Dosimetry solution, introduced in 2012, helps physicians and clinical staff visualize X-ray exposure in real time using easy-to-read bar graphs displayed on a monitor. The instant feedback empowers medical staff to adapt their behavior around radiation, to help minimize unnecessary exposure.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now